Northpond Ventures, LLC 13F Holdings · last filed Q3 2024
Northpond Ventures, LLC reported 3 securities worth $43.66M in its SEC 13F filing for Q3 2024 (period ended 2024-09-30). Top holdings: KYTX (36.46%), VIGL (32.82%), CADL (30.72%). Among its top 25 positions this quarter: 1 exited.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | KYTX | KYVERNA THERAPEUTICS INC | $15.9M | 36.46% | 3.3M | Hold |
| 2 | VIGL | VIGIL NEUROSCIENCE INC | $14.3M | 32.82% | 4.2M | Hold |
| 3 | CADL | CANDEL THERAPEUTICS INC | $13.4M | 30.72% | 1.9M | Hold |
| 4 | TBIO | TELESIS BIO INC | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2024-09-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR